GERON CORP (GERN) ROI
- 2024-09-30: ROI -53.49%.
- 2024-06-30: ROI -56.28%.
- 2024-03-31: ROI -47.10%.
- 2023-12-31: ROI -55.81%.
Complete source-backed roi history.
- Available history
- 2022-06-30 to 2024-09-30
- Data captured
Historical ROI
| Date | ROI |
|---|
| 2024-09-30 | -53.49% |
|---|
| 2024-06-30 | -56.28% |
|---|
| 2024-03-31 | -47.10% |
|---|
| 2023-12-31 | -55.81% |
|---|
| 2023-09-30 | -51.03% |
|---|
| 2023-06-30 | -48.86% |
|---|
| 2023-03-31 | -39.72% |
|---|
| 2022-12-31 | -108.19% |
|---|
| 2022-09-30 | -82.60% |
|---|
| 2022-06-30 | -60.75% |
|---|
Annual ROI
| Date | ROI |
|---|
| 2023-12-31 | -55.81% |
|---|
| 2022-12-31 | -108.19% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
|---|
| Wave Life Sciences, Inc. (WVE) | | $0.780B | -5.56 |
|---|
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
|---|
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
|---|